John M. Talmadge, M.D.
Director, Addiction Psychiatry Fellowship Training Program
Associate Professor of Psychiatry
University of Texas Southwestern Medical Center
Dr. Talmadge has disclosed that, in the past 12 months, he has been a member of the speakers bureaus for Astra-Zeneca, Eli Lilly, Forest Pharmaceuticals, and Janssen. He has no current industry relationships to disclose. The editors of The Carlat Report have closely reviewed the content of Dr. Talmadge’s interview and have determined that there are no financial conflicts of interest regarding this educational activity.
Dr. Talmadge, in your practice, do you ever prescribe benzodiazepines to people with substance abuse histories?
Viibryd has gone generic, but is it worth prescribing? We review all there is to know about vilazodone in this update from our #1 most read article of 2023.